One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management
Regular follow-up with the bariatric multidisciplinary team ensures optimal long-term management and allows for adjustment of treatment strategies as needed
Nausea peaks 24-48 hours after injection and fades over the following 2-3 days
While there is no absolute contraindication to tirzepatide use in autoimmune disease, several safety considerations warrant attention
Why Some People Lose Less Than Expected Its easy to feel discouraged when weight loss doesnt match expectations
The few fine lines I have were softened, and the overall texture looked smoother and fresher
